TACE

[tās]

trademark for preparations of chlorotrianisene, a synthetic estrogen used for palliative treatment of prostate cancer and for replacement therapy.

ADAM1bha17

An ADAMs family protein encoded by ADAM17 on chromosome 2p25, which acts as a tumour necrosis factor-alpha converting enzyme (TACE). It binds mitotic arrest-deficient 2 protein, and plays a key role in activating Notch signalling, resulting in the proteolytic release of cell-surface proteins, including p75 TNF-receptor, IL-1 receptor type II, p55 TNF-receptor, TGF-alpha, L-selectin, growth hormone receptor, MUC1 and amyloid precursor protein (APP).

Mentioned in

References in periodicals archive

BCLC: Barcelona Clinic Liver Cancer; RFA: radiofrequency ablation therapy; TACE: transarterial chemoembolization; TAE: transarterial embolization.

Assessing the characteristics and feasibility of preventing early mortality in patients with hepatocellular carcinoma

The immediate CT scan revealed that lipiodol was concentrated in the tumor and the effect of TACE was significant.

Angio-Computed Tomograph-Guided Immediate Lipiodol Computed Tomograph for Diagnosis of Small Hepatocellular Carcinoma Lesions during Transarterial Chemoembolization

All patients underwent quadruple-phase MDCT (unenhanced, arterial, portal venous, delayed phases) before and after TACE. MDCT images were obtained using a 64-row helical CT scanner) (SOMATOM Definition, Siemens Medical Solutions) with the following scanning protocol: tube voltage, 80-100 kVp; beam collimation, 14x1.2 mm; pitch, 0.6; tube current product value, 180 mAs; rotation time, 0.5 s.

Usefulness of fusion images of unenhanced and contrast-enhanced arterial phase cone-beam CT in the detection of viable hepatocellular carcinoma during transarterial chemoembolization

TACE = transcatheter arterial chemoembolization, RFA = radiofrequency ablation, Y-90 = yttrium-90 radioembolization, and SBRT = stereotactic body radiation therapy.

Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients

Five weeks after undergoing TACE, he was readmitted with hematochezia and hemorrhagic shock.

Rupture of Hepatocellular Carcinoma after Transarterial Chemoembolization followed by Massive Gastric Bleeding

For liver metastasis rupture during initial treatment, TACE and HAIC with 5FU/ CDDP were performed for volume control.

The Effectiveness of Hepatic Arterial Infusion Chemotherapy with 5-Fluorouracil/Cisplatin and Systemic Chemotherapy with Ramucirumab in Alpha-Fetoprotein-Producing Gastric Cancer with Multiple Liver Metastases

Variables AFP [greater AFP < 20 ng/ml P than or equal to] 20 ng/ml First-line chemotherapy regimens Platinum-based doublet 46 (62.2%) 156 (63.7%) regimen Taxane-based doublet 13 (17.6%) 44 (18.0%) regimen Triplet regimen 9 (12.2%) 17 (6.9%) 0.325 Single-drug regimen 6 (8.1%) 19 (7.8%) Others 0 (0.0%) 9 (3.7%) Response of first-line chemotherapy PR 28 (41.2%) 106 (56.1%) 0.024 SD + PD 40 (58.8%) 83 (43.9%) Subsequent therapies after the first-line chemo Second-line chemotherapy Yes 24 (40.0%) 97 (53.0%) 0.055 No 36 (60.0%) 86 (47.0%) Surgery treatment Yes 1 (1.4%) 8 (3.3%) 0.344 No 73 (98.6%) 237 (96.7%) Local treatment of LM (a) Yes 23 (31.1%) 60 (24.5%) 0.163 No 51 (68.9%) 185 (75.5%) (a) Including TACE, ablation, radiotherapy, and liver resection.

Multimodality Treatment Including Triplet Regimen as First-Line Chemotherapy May Improve Prognosis of Serum AFP-Elevated Gastric Cancer with Liver Metastasis

AFP: Alpha-fetoprotein HCC: Hepatocellular carcinoma LT: Liver transplantation TACE: Transarterial chemoembolization.

Blood Transfusions and Tumor Biopsy May Increase HCC Recurrence Rates after Liver Transplantation

A 57-year-old male with a past medical history of cirrhosis and HCC secondary to chronic alcohol abuse and hepatitis C infection was undergoing serial transarterial chemoembolization (TACE) procedures.

Nuclear Imaging to Detect Diaphragmatic Perforation as a Rare Complication of Microwave Ablation